<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04814134</url>
  </required_header>
  <id_info>
    <org_study_id>CLN-1051-001</org_study_id>
    <nct_id>NCT04814134</nct_id>
  </id_info>
  <brief_title>CPNS Pilot Study: Evaluation of Safety and Performance of the Cardiac Pulmonary Nerve Stimulation (CPNS) System in Patients With ADHF</brief_title>
  <official_title>The Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardionomic Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardionomic Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The CPNS Pilot Study: An evaluation of the safety and performance of the Cardionomic Cardiac&#xD;
      Pulmonary Nerve Stimulation (CPNS) system in patients with acute decompensated heart failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CPNS Pilot Study is a prospective, multi-center and multinational study to evaluate the&#xD;
      safety and performance of the CPNS System in patients hospitalized with acute decompensated&#xD;
      heart failure (ADHF). The CPNS System is a neuromodulation system, intended to provide acute&#xD;
      (≤5 days) endovascular stimulation of the cardiac autonomic nerves in the right pulmonary&#xD;
      artery. The system consists of a temporary neuromodulation stimulator catheter and a&#xD;
      stimulator. Approximately 50 patients will be enrolled in the study and will be followed up&#xD;
      through 6-months post-discharges from the hospital. Patients assigned to the treatment group&#xD;
      will receive CPNS therapy and followed closely in an intensive care unit setting. Patients&#xD;
      randomized to the control arm in Phase 2 will receive standard treatment for their heart&#xD;
      failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects will be assigned to CPNS treatment or to the control arm. Treatment with CPNS system includes endovascular stimulation of the cardiac autonomic nerves in addition to standard of care. Subjects in the control arm will receive the available standard treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety Measures</measure>
    <time_frame>6 months</time_frame>
    <description>The occurrence of all system and/or procedure related adverse events and serious adverse events and deaths</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Decompensated Heart Failure</condition>
  <arm_group>
    <arm_group_label>CPNS Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with CPNS system: Endovascular stimulation of the cardiac autonomic nerves in addition to standard of care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Available standard treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPNS Therapy</intervention_name>
    <description>Endovascular stimulation of the cardiac autonomic nerves in addition to standard of care</description>
    <arm_group_label>CPNS Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Available standard treatment</description>
    <arm_group_label>CPNS Therapy</arm_group_label>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to hospital with a principal diagnosis of ADHF&#xD;
&#xD;
          -  BMI adjusted BNP ≥ 500 pg/mL or NT-proBNP ≥ 2000 pg/mL&#xD;
&#xD;
          -  LVEF ≤ 45%&#xD;
&#xD;
          -  At least one sign/symptom of fluid overload&#xD;
&#xD;
          -  At least one of the following:&#xD;
&#xD;
               -  inadequate diuretic response&#xD;
&#xD;
               -  least one sign or symptom of low perfusion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  First IV treatment upon presentation in hospital to randomization &gt; 48 hours&#xD;
&#xD;
          -  Received an inotrope or anticipated to receive an inotrope in the 12 hours following&#xD;
             enrollment&#xD;
&#xD;
          -  Requires mechanical support or anticipated to receive mechanical support in the 12&#xD;
             hours following enrollment&#xD;
&#xD;
          -  Systolic blood pressure &lt; 80mmHg or &gt; 130mmHg&#xD;
&#xD;
          -  Symptomatic hypotension&#xD;
&#xD;
          -  eGFR &lt; 25 mL/min/1.732&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michelle Kennefick</last_name>
    <phone>6516331388</phone>
    <email>clinical@cardionomicinc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospitals</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>OLV Ziekenhuis</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Jan Brugge</name>
      <address>
        <city>Bruges</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Punta Pacifica</name>
      <address>
        <city>Panama City</city>
        <country>Panama</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Panama</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurostimulation</keyword>
  <keyword>Contractility</keyword>
  <keyword>Right Pulmonary Artery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

